by Laval University Credit: Pixabay/Pete Linforth. Researchers from the Université Laval Faculty of Medicine and CHU de Québec–Université Laval Research Center have successfully edited the genome of human cells grown in vitro to introduce a mutation providing protection against Alzheimer’s disease. The details of this breakthrough were recently published in The CRISPR Journal. “Some genetic mutations increase the...
15 things not to do when using a rapid antigen test, from storing in the freezer to sampling snot
by Thea Van de Mortel, The Conversation Credit: Shutterstock Many of us have taken a rapid antigen test (RAT) or have administered them to our school-aged children. But how many of us are using them correctly? Here are 15 pitfalls to avoid if you want to get the most out of your RAT. 1. Storing...
Men with high levels of body fat may be at risk for osteoporosis
by The Endocrine Society Men with high levels of body fat have lower bone density and may be more likely to break a bone than those with normal levels of body fat, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Most studies have shown positive or neutral effects of...
Study finds it safe to give clot-busting drug to stroke patients who took blood thinners
by UT Southwestern Medical Center Credit: CC0 Public Domain Stroke patients on long-term blood thinners who were given the clot-busting drug alteplase enjoyed better recoveries than those who did not receive the drug and had no increased risk of bleeding, a new study led by UTSW researchers shows. The results run counter to the common...
From ‘super-recognisers’ to the ‘face blind’: How tests reveal underlying cognitive processes
by Karen Lander, The Conversation ‘Have we met?’ Actor Brad Pitt thinks he is faceblind. Credit: Matteo Chinellato/Shutterstock The ability to recognize faces is important in many different real life contexts and fundamental to our social relationships and interactions. It allows us to identify people we care about, and respond appropriately to them. We may...
Animal-based protein recommended for people being treated for cancer
by Bev Betkowski, University of Alberta U of A professor Carla Prado is a co-author of a new opinion paper recommending that people being treated for cancer should get at least 65 percent of their protein from animal-based sources. Credit: Faculty of ALES If you’re being treated for cancer, don’t leave meat, fish and dairy...
Challenges of deprescribing and minimizing use of anticholinergic medications
by Regenstrief Institute Credit: CC0 Public Domain Medications with anticholinergic properties have been consistently associated with a wide range of adverse outcomes for older adults including cognitive impairment, yet these drugs continue to be commonly prescribed for depression, urinary incontinence, irritable bowel syndrome and Parkinson’s disease. In an editorial published in the peer-reviewed journal Frontiers...
Research team discovers expanded role for brain’s sensory processing center
by Georgia Institute of Technology Garrett Stanley and Christian Waiblinger. Credit: Georgia Tech / Jerry Grillo When you start learning how to do something new, like swinging a tennis racket or playing a musical instrument, the simplest tasks can feel difficult. Shifting from one chord to another on a guitar can require a lot of...
A genetic difference affects the likelihood of severe COVID-19 infection
by Alex Dadswell, Imperial College London On the left, a solid representation of the three-dimensional structure of TMPRSS2 protein. On the right, a cartoon representation of the three-dimensional structure of the TMPRSS2 protein with an expanded view showing the switch from the amino acid valine (Val, top panel) to methionine (Met, bottom panel) caused by...
A machine-learning approach to managing diabetes and cardiovascular risk
by Elisabeth Reitman, Yale University Credit: CC0 Public Domain A novel online tool called INSIGHT offers a machine learning-based approach when prescribing sodium-glucose cotransporter-2 (SGLT2) inhibitors to maximize the benefit for patients with Type 2 diabetes. The study, led by Yale researcher Rohan Khera, MD, MS, appears February 4 in the journal Diabetes Care. The study’s first...